Keyphrases
Narcolepsy
98%
Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD)
80%
Polysomnography
72%
Obstructive Sleep Apnea
53%
Rapid Eye Movement Sleep
45%
Parkinson's Disease
39%
Hypocretin
38%
Sleep Disorders
30%
REM Sleep
30%
Melatonin
29%
Sleep Quality
28%
Sleep Apnea
27%
Rheumatoid Arthritis
27%
Sleep Disturbance
26%
Sleep-disordered Breathing
25%
Healthy Controls
25%
Randomized Controlled Trial
24%
Denmark
24%
Confidence Interval
22%
Electroencephalography
22%
Snoring
21%
Insomnia
19%
Economic Consequences
18%
Epilepsy
18%
Control Subjects
17%
Comorbidity
17%
Circadian Rhythm
17%
Sleep Stages
17%
Disturbed Sleep
16%
Arousal
16%
Rapid Eye Movement
15%
Health Consequences
15%
Socio-economic Impact
15%
Europe
15%
Actigraphy
15%
Cerebrospinal Fluid
15%
Social Consequences
15%
Register Study
14%
Cluster Headache
14%
Health Care Costs
14%
Parkinson Patients
14%
Patients with Parkinson's Disease
13%
Critically Ill Patients
13%
Childhood-onset
13%
Wakefulness
13%
Neurodegenerative Diseases
12%
Copenhagen
12%
Stroke Patients
12%
All-cause Mortality
12%
Pediatric Narcolepsy
12%
Neuroscience
Rapid Eye Movement Sleep
100%
Narcolepsy
77%
Obstructive Sleep Apnea
67%
Parkinson's Disease
51%
Behavior Disorder
45%
Sleep Disorder
45%
Polysomnography
44%
Rapid Eye Movement Sleep Behavior Disorder
39%
Melatonin
29%
Orexin
29%
Sleep Stage
25%
Sleep Quality
22%
Hypersomnia
19%
Orexin-A
19%
Electroencephalography
18%
Electroencephalography
17%
Cataplexy
16%
Wakefulness
13%
Actigraphy
13%
Circadian Rhythm
13%
Somnolence
13%
Cluster Headache
13%
Daytime Somnolence
13%
Limb Movement
12%
Neurodegenerative Disorder
12%
Randomized Controlled Trial
11%
Sleep Time
11%
Benzodiazepine
11%
Sleep Spindle
11%
Transcranial Magnetic Stimulation
10%
Neural Network
10%
Electroencephalogram
10%
Rheumatoid Arthritis
9%
Eye Movement
9%
Meta-Analysis
9%
Cortisol
9%
Sleep Pattern
9%
Electromyography
9%
Non-Rapid Eye Movement Sleep
8%
Body Mass Index
8%
Cognitive Behavioral Therapy
8%
Epileptic Absence
8%
Psychoactive Drug
8%
Restless Legs Syndrome
8%
Dementia Praecox
8%
Neurodegeneration
8%
Cognitive Disorders
7%
Motor Evoked Potential
7%
Placebo
7%
Hypothalamus
7%